Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & Administrative
Others
Ratios

Bluejay Diagnostics (BJDX) EPS (Weighted Average and Diluted) (2022 - 2023)

Bluejay Diagnostics (BJDX) has disclosed EPS (Weighted Average and Diluted) for 2 consecutive years, with -$3573.1 as the latest value for Q4 2023.

  • Quarterly EPS (Weighted Average and Diluted) fell 146719.67% to -$3573.1 in Q4 2023 from the year-ago period, while the trailing twelve-month figure was -$75.27 through Sep 2023, down 2599.02% year-over-year, with the annual reading at -$15.25 for FY2025, 96.66% up from the prior year.
  • EPS (Weighted Average and Diluted) hit -$3573.1 in Q4 2023 for Bluejay Diagnostics, down from -$16.67 in the prior quarter.
  • In the past five years, EPS (Weighted Average and Diluted) ranged from a high of -$0.1 in Q1 2022 to a low of -$3573.1 in Q4 2023.